Ludwig Hantson, CEO at ALEXION PHARMACEUTICALS INC (ALXN), sold 5,106 shares at $121.63 ($621K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $621k ALXN by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.63 | 2,553 | $311K | 50.0% |
| 2 | $121.63 | 2,553 | $311K | 50.0% |
| Total | $121.63 avg | 5,106 | $621K | 100% |
| Filing → |
| ALXN | BUY | 2017-06-19 | $1.2M | — | Filing → |
| BAX | SELL | 2014-07-11 | $1.9M | — | Filing → |
| BAX | SELL | 2013-01-29 | $710K | — | Filing → |